Shobayashi T - Search Results

1

Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis.

Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA, Carlino LO, Owen R, Paterson B, Pelletier L, Vachon J, Gonzalez C, Hongjie Y, Zijian F, Chuang SK, Au A, Buda S, Krause G, Haas W, Bonmarin I, Taniguichi K, Nakajima K, Shobayashi T, Takayama Y, Sunagawa T, Heraud JM, Orelle A, Palacios E, van der Sande MA, Wielders CC, Hunt D, Cutter J, Lee VJ, Thomas J, Santa-Olalla P, Sierra-Moros MJ, Hanshaoworakul W, Ungchusak K, Pebody R, Jain S, Mounts AW; WHO Working Group for Risk Factors for Severe H1N1pdm Infection. Van Kerkhove MD, et al. Among authors: shobayashi t. PLoS Med. 2011 Jul;8(7):e1001053. doi: 10.1371/journal.pmed.1001053. Epub 2011 Jul 5. PLoS Med. 2011. PMID: 21750667 Free PMC article.

2

Underlying medical conditions and hospitalization for pandemic (H1N1) 2009, Japan.

Tomizuka T, Takayama Y, Shobayashi T, Fukushima Y, Suzuki Y. Tomizuka T, et al. Among authors: shobayashi t. Emerg Infect Dis. 2010 Oct;16(10):1646-7. doi: 10.3201/eid1610.091755. Emerg Infect Dis. 2010. PMID: 20875306 Free PMC article. No abstract available.

3

Introduction of a hepatitis B vaccine into the national routine immunisation programme of Japan.

Ujiie M, Sasaki K, Yoshikawa N, Enami T, Shobayashi T. Ujiie M, et al. Among authors: shobayashi t. Lancet Infect Dis. 2016 Dec;16(12):1325. doi: 10.1016/S1473-3099(16)30463-7. Epub 2016 Nov 15. Lancet Infect Dis. 2016. PMID: 27998586 No abstract available.

4

[The surveillance system of communicable diseases based on the Communicable Diseases law and the utilization of the data collected].

Shobayashi T. Shobayashi T. Nihon Rinsho. 2007 Mar 28;65 Suppl 3:13-22. Nihon Rinsho. 2007. PMID: 17491359 Japanese. No abstract available.

5

Rubella outbreak in Japan.

Ujiie M, Nabae K, Shobayashi T. Ujiie M, et al. Among authors: shobayashi t. Lancet. 2014 Apr 26;383(9927):1460-1461. doi: 10.1016/S0140-6736(14)60712-1. Lancet. 2014. PMID: 24766958 No abstract available.

6

Trends in Policy on the Prevention and Control of Non-Communicable Diseases in Japan.

Ezoe S, Noda H, Akahane N, Sato O, Hama T, Miyata T, Terahara T, Fujishita M, Sakamoto H, Abe SK, Gilmour S, Shobayashi T. Ezoe S, et al. Among authors: shobayashi t. Health Syst Reform. 2017 Oct 2;3(4):268-277. doi: 10.1080/23288604.2017.1347125. Health Syst Reform. 2017. PMID: 30359179 Free article.

7

History of nutrition policy in Japan.

Shobayashi T. Shobayashi T. Nutr Rev. 2020 Dec 1;78(12 Suppl 2):10-13. doi: 10.1093/nutrit/nuaa078. Nutr Rev. 2020. PMID: 33259615 Review.

8

Exposure Assessment of Environmental Tobacco Aerosol from Heated Tobacco Products: Nicotine and PM Exposures under Two Limited Conditions.

Hirano T, Shobayashi T, Takei T, Wakao F. Hirano T, et al. Among authors: shobayashi t. Int J Environ Res Public Health. 2020 Nov 18;17(22):8536. doi: 10.3390/ijerph17228536. Int J Environ Res Public Health. 2020. PMID: 33217889 Free PMC article.

9

[Analysis of factors determining transfusion albumin usage in different prefectures].

Shobayashi T, Kamiyama Y, Kawaguchi T, Takano M, Satoh T. Shobayashi T, et al. Nihon Koshu Eisei Zasshi. 2003 Oct;50(10):980-7. Nihon Koshu Eisei Zasshi. 2003. PMID: 14639959 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters